| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046954131 |
| P356 | DOI | 10.1007/S10815-011-9608-7 |
| P932 | PMC publication ID | 3169679 |
| P698 | PubMed publication ID | 21743973 |
| P5875 | ResearchGate publication ID | 51481505 |
| P2093 | author name string | Ashok Agarwal | |
| Kim Dao Ly | |||
| Zsolt Peter Nagy | |||
| P2860 | cites work | Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | Q24244735 |
| Uniparental disomy as a mechanism for human genetic disease | Q24679370 | ||
| Preimplantation diagnosis for Fanconi anemia combined with HLA matching | Q28203871 | ||
| Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis | Q28272055 | ||
| Comparative genomic hybridization analysis of human oocytes and polar bodies | Q30815751 | ||
| Comparison of the results of human embryo biopsy and outcome of PGD after zona drilling using acid Tyrode medium or a laser | Q30976958 | ||
| ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003. | Q31005822 | ||
| ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006. | Q31163853 | ||
| Comparison of effects of zona drilling by non-contact infrared laser or acid Tyrode's on the development of human biopsied embryos as revealed by blastomere viability, cytoskeletal analysis and molecular cytogenetics | Q33231802 | ||
| Comparison of laser-assisted hatching and acidified Tyrode's hatching by evaluation of blastocyst development rates in sibling embryos: a prospective randomized trial | Q33238913 | ||
| Screening oocytes by polar body biopsy | Q33248822 | ||
| Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study | Q33270799 | ||
| New insights into human nondisjunction of chromosome 21 in oocytes | Q33325904 | ||
| ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. | Q33436560 | ||
| ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008. | Q33683144 | ||
| Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol | Q33731973 | ||
| Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. | Q33872742 | ||
| Anaphase lagging mainly explains chromosomal mosaicism in human preimplantation embryos | Q75345880 | ||
| Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters | Q78290635 | ||
| Preimplantation aneuploidy screening using comparative genomic hybridization or fluorescence in situ hybridization of embryos from patients with recurrent implantation failure | Q79160322 | ||
| Application of three-dimensional fluorescence in situ hybridization to human preimplantation genetic diagnosis | Q79806042 | ||
| Comparison of the aneuploidy frequency in embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men | Q80087580 | ||
| Nuclear chromosomal localization in human preimplantation embryos: correlation with aneuploidy and embryo morphology | Q80425448 | ||
| Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial | Q81533938 | ||
| Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now? | Q82635497 | ||
| Embryo biopsy: the fate of abnormal pronuclear embryos | Q82954112 | ||
| Successful pregnancies after application of array-comparative genomic hybridization in PGS-aneuploidy screening | Q82954172 | ||
| Pronuclear morphology differs between women more than 38 and women less than 30 years of age | Q83504889 | ||
| ACOG Committee Opinion No. 430: preimplantation genetic screening for aneuploidy | Q83507685 | ||
| The importance of good practice in preimplantation genetic screening: critical viewpoints | Q83880741 | ||
| The analysis of one or two blastomeres for PGD using fluorescence in-situ hybridization | Q83994647 | ||
| Two cases of trisomy 16 mosaicism ascertained postnatally | Q84077719 | ||
| The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender | Q84384005 | ||
| Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes | Q84785638 | ||
| ESHRE PGD Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS) | Q85239152 | ||
| ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD | Q85239157 | ||
| ESHRE PGD consortium best practice guidelines for amplification-based PGD | Q85239160 | ||
| Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. | Q33880192 | ||
| SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts | Q34007983 | ||
| Sperm centriole disfunction and sperm immotility | Q34034051 | ||
| Analysis of the first polar body: preconception genetic diagnosis | Q34278766 | ||
| The use of first polar bodies for preimplantation diagnosis of aneuploidy | Q34303308 | ||
| Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification | Q34321635 | ||
| Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. | Q34357019 | ||
| Single-embryo transfer | Q34419458 | ||
| Cost-effectiveness of in vitro fertilization | Q34419469 | ||
| Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. | Q34440975 | ||
| Fluorescence in situ hybridization reanalysis of day-6 human blastocysts diagnosed with aneuploidy on day 3. | Q34465927 | ||
| Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts | Q34477292 | ||
| Molecular diagnostics in preimplantation genetic diagnosis | Q34516018 | ||
| Developmental ability of chromosomally abnormal human embryos to develop to the blastocyst stage | Q34517295 | ||
| Potential significance of genomic imprinting defects for reproduction and assisted reproductive technology | Q34546139 | ||
| Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays | Q34617227 | ||
| Sex matters in meiosis | Q34699921 | ||
| Preimplantation diagnosis for diseases with genetic predisposition and nondisease testing | Q34884761 | ||
| The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis | Q34981324 | ||
| Current features of preimplantation genetic diagnosis. | Q35019154 | ||
| The basis and significance of pre–patterning in mammals | Q35213661 | ||
| First-meiotic-division nondisjunction in human oocytes | Q35248934 | ||
| Multiple births from assisted reproductive technologies: a challenge that must be met. | Q35705536 | ||
| Association between nondisjunction and maternal age in meiosis-II human oocytes | Q35882916 | ||
| Different probe combinations for assessment of postzygotic chromosomal imbalances in human embryos | Q36271289 | ||
| Mechanisms of aneuploidy induction in human oogenesis and early embryogenesis | Q36271546 | ||
| Chromosome abnormalities and their relationship to morphology and development of human embryos | Q36396448 | ||
| Preimplantation genetic diagnosis: an overview of socio-ethical and legal considerations | Q36489195 | ||
| PGD for aneuploidy screening: an expensive hoax? | Q36644702 | ||
| Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process | Q36832052 | ||
| Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age. | Q37033768 | ||
| Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. | Q37091050 | ||
| Spermiogenesis and DNA repair: a possible etiology of human infertility and genetic disorders | Q37187725 | ||
| IVF/ICSI with or without preimplantation genetic screening for aneuploidy in couples without genetic disorders: a systematic review and meta-analysis | Q37284506 | ||
| First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell anemia | Q48918099 | ||
| Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone | Q48932629 | ||
| Pronuclear morphology predicts embryo development and chromosome constitution | Q49265805 | ||
| Does PGD for aneuploidy screening change the selection of embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men? | Q50109837 | ||
| Oocyte euploidy, pronuclear zygote morphology and embryo chromosomal complement. | Q50645612 | ||
| Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. | Q50646619 | ||
| Cytogenetic analysis of human oocytes remaining unfertilized after intracytoplasmic sperm injection. | Q50650884 | ||
| Wide range of chromosome abnormalities in the embryos of young egg donors. | Q50651270 | ||
| Evidence of a high proportion of premature unbalanced separation of sister chromatids in the first polar bodies of women of advanced age. | Q50653770 | ||
| The fate of mosaic aneuploid embryos during mouse development. | Q50654709 | ||
| In vitro oocyte maturation and subsequent delayed fertilization is associated with increased embryo aneuploidy. | Q50656699 | ||
| Karyotyping of human oocytes by cenM-FISH, a new 24-colour centromere-specific technique. | Q50658208 | ||
| Reliability of comparative genomic hybridization to detect chromosome abnormalities in first polar bodies and metaphase II oocytes. | Q50672829 | ||
| Elective single embryo transfer: the value of cryopreservation. | Q50715065 | ||
| Birth of healthy children after preimplantation diagnosis of common aneuploidies by polar body fluorescent in situ hybridization analysis. Preimplantation Genetics Group. | Q50761621 | ||
| Assessment of numeric abnormalities of X, Y, 18, and 16 chromosomes in preimplantation human embryos before transfer. | Q50762701 | ||
| Preimplantation genetic diagnosis principles and ethics. | Q51094453 | ||
| Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. | Q51678170 | ||
| The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. | Q51720336 | ||
| Different embryonic development after blastomere biopsy for preimplantation genetic diagnosis, observed by time-lapse imaging. | Q51936953 | ||
| Preimplantation aneuploid embryos undergo self-correction in correlation with their developmental potential. | Q51948445 | ||
| Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. | Q51968796 | ||
| Neurological sequelae in children born after in-vitro fertilisation: a population-based study. | Q52123623 | ||
| Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. | Q52206925 | ||
| Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. | Q53293819 | ||
| ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. | Q53294162 | ||
| The impact of LH-containing gonadotropin stimulation on euploidy rates in preimplantation embryos: antagonist cycles. | Q53455830 | ||
| What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. | Q53472614 | ||
| Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. | Q53552393 | ||
| Embryo morphology and development are dependent on the chromosomal complement. | Q53586766 | ||
| Is the plane of first cleavage related to the point of sperm entry in the mouse? | Q53656985 | ||
| Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. | Q54632231 | ||
| Guidelines for good practice in PGD: programme requirements and laboratory quality assurance. | Q54714247 | ||
| Identification of differentially expressed mRNAs in bovine preimplantation embryos. | Q54785366 | ||
| The combination of polar body and embryo biopsy does not affect embryo viability | Q57001976 | ||
| Clinical application of comprehensive chromosomal screening at the blastocyst stage | Q57779161 | ||
| Selection of embryos by morphology is less effective than by a combination of aneuploidy testing and morphology observations | Q57779196 | ||
| Increased efficiency of preimplantation genetic diagnosis for infertility using “no result rescue” | Q57779224 | ||
| Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates | Q57779232 | ||
| Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multicenter study | Q57779247 | ||
| Chromosomal abnormalities in embryos derived from testicular sperm extraction | Q57779314 | ||
| Sperm quality may adversely affect the chromosome constitution of embryos that result from intracytoplasmic sperm injection | Q57779420 | ||
| Sperm chromosomal abnormalities are linked to sperm morphologic deformities | Q58226668 | ||
| In Vitro Fertilization with Preimplantation Genetic Screening | Q59782826 | ||
| Preimplantation genetic diagnosis. In situ hybridization as a tool for analysis | Q68089002 | ||
| Diagnosis of major chromosome aneuploidies in human preimplantation embryos | Q72347419 | ||
| Chromosome mosaicism in human embryos | Q72365258 | ||
| Detection of DNA copy number changes in human endometriosis by comparative genomic hybridization | Q73274297 | ||
| Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization | Q73621662 | ||
| Improved implantation after preimplantation genetic diagnosis of aneuploidy | Q73832631 | ||
| Elective single embryo transfer: a 6-year progressive implementation of 784 single blastocyst transfers and the influence of payment method on patient choice | Q37314404 | ||
| Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. | Q37466984 | ||
| Preimplantation genetic diagnosis: state of the art. | Q37467883 | ||
| Centrioles in the beginning of human development | Q37523526 | ||
| Current trends, biological foundations and future prospects of oocyte and embryo cryopreservation | Q37539037 | ||
| Uniparental disomy and the phenotype of mosaic trisomy 20: a new case and review of the literature | Q37564857 | ||
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | Q37689134 | ||
| Embryo aneuploidy and the role of morphological and genetic screening | Q37778166 | ||
| Sequential FISH analysis using competitive displacement of labelled peptide nucleic acid probes for eight chromosomes in human blastomeres | Q38331564 | ||
| Fluorescence in situ hybridization analysis of human oocytes: advantages of a double-labeling procedure | Q38476905 | ||
| Reliability of short comparative genomic hybridization in fibroblasts and blastomeres for a comprehensive aneuploidy screening: first clinical application | Q39701820 | ||
| What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee | Q39904266 | ||
| Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics | Q40194292 | ||
| Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial | Q40254344 | ||
| Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval. | Q40271383 | ||
| The incidence, origin, and etiology of aneuploidy | Q41080526 | ||
| Oocyte polarity and cell determination in early mammalian embryos | Q41658998 | ||
| An estimate of the cost of in vitro fertilization services in the United States in 1995 | Q42680644 | ||
| Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. | Q43688571 | ||
| Cytogenetic analysis of giant oocytes and zygotes to assess their relevance for the development of digynic triploidy | Q44119052 | ||
| Predivision in human oocytes at meiosis I: a mechanism for trisomy formation in man. | Q44158682 | ||
| Experimental analysis of second cleavage in the mouse | Q44232641 | ||
| Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial | Q44316456 | ||
| Blastomere fixation techniques and risk of misdiagnosis for preimplantation genetic diagnosis of aneuploidy | Q44412800 | ||
| No beneficial effect of preimplantation genetic screening in women of advanced maternal age with a high risk for embryonic aneuploidy | Q44885065 | ||
| Day-3 embryo morphology predicts euploidy among older subjects. | Q45950670 | ||
| Ovarian stimulation and the risk of aneuploid conceptions | Q45984200 | ||
| Preimplantation genetic screening in older women: a cost-effectiveness analysis. | Q46027773 | ||
| Accuracy of FISH analysis in predicting chromosomal status in patients undergoing preimplantation genetic diagnosis | Q46184860 | ||
| Morbidity in a Danish national cohort of 472 IVF/ICSI twins, 1132 non-IVF/ICSI twins and 634 IVF/ICSI singletons: health-related and social implications for the children and their families | Q46349074 | ||
| Differences in chromosome susceptibility to aneuploidy and survival to first trimester | Q47226926 | ||
| ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. | Q47626578 | ||
| Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure | Q48718141 | ||
| Prognostic value of sperm fluorescence in situ hybridization analysis over PGD. | Q48725524 | ||
| Comprehensive molecular cytogenetic analysis of the human blastocyst stage | Q48743163 | ||
| Reproductive oocyte/embryo genetic analysis: comparison between fluorescence in-situ hybridization and comparative genomic hybridization | Q48783381 | ||
| The influence of sperm morphology on preimplantation genetic diagnosis cycles outcome | Q48784587 | ||
| Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles | Q48792044 | ||
| Lack of association between polycystic ovary syndrome and embryonic aneuploidy | Q48795180 | ||
| Duplication of the sperm genome by human androgenetic embryo production: towards testing the paternal genome prior to fertilization | Q48795367 | ||
| Aneuploidy study of human oocytes first polar body comparative genomic hybridization and metaphase II fluorescence in situ hybridization analysis. | Q48808126 | ||
| Chromosome abnormalities in 1255 cleavage-stage human embryos | Q48827038 | ||
| Assessment of beta-HCG, beta-LH mRNA and ploidy in individual human blastomeres | Q48846627 | ||
| First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy | Q48852165 | ||
| Mechanisms of non-disjunction in human female meiosis: the co-existence of two modes of malsegregation evidenced by the karyotyping of 1397 in-vitro unfertilized oocytes | Q48854145 | ||
| Spectral karyotyping of fresh, non-inseminated oocytes | Q48859511 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 833-849 | |
| P577 | publication date | 2011-07-09 | |
| P1433 | published in | Journal of Assisted Reproduction and Genetics | Q15755113 |
| P1476 | title | Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo? | |
| P478 | volume | 28 |
| Q36434649 | A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice |
| Q30848229 | A simple, less invasive stripper micropipetter-based technique for day 3 embryo biopsy |
| Q38764891 | Application of microfluidic technologies to human assisted reproduction |
| Q34944766 | Blood pressure and anthropometrics of 4-y-old children born after preimplantation genetic screening: follow-up of a unique, moderately sized, randomized controlled trial |
| Q42416813 | Challenges of Genetic Screening of In Vitro Fertilized Human Embryos Using Current Technologies |
| Q39014528 | Clinical outcomes for couples containing a reciprocal chromosome translocation carrier without preimplantation genetic diagnosis |
| Q37037926 | Comprehensive chromosome analysis of blastocysts before implantation using array CGH. |
| Q38017130 | Comprehensive genetic assessment of the human embryo: can empiric application of microarray comparative genomic hybridization reduce multiple gestation rate by single fresh blastocyst transfer? |
| Q47217831 | Developmental outcome of 9-year-old children born after PGS: follow-up of a randomized trial |
| Q57140976 | Do patients who achieve pregnancy using IVF-PGS do the recommended genetic diagnostic testing in pregnancy? |
| Q46316736 | In vitro maturation and surrogacy in patients with vascular-type Ehlers-Danlos syndrome--a safe assisted reproductive technology approach |
| Q45304413 | Preimplantation genetics and other reproductive options in Huntington disease |
| Q35974858 | Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study |
| Q43476409 | Refuting a misguided campaign against the goal of single-embryo transfer and singleton birth in assisted reproduction |
| Q36112761 | Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study |
| Q37024910 | Successful birth of South India's first twins after preimplantation genetic screening of embryos |
| Q38954609 | The state of "freeze-for-all" in human ARTs |
Search more.